CN103242223A - Preparation method of 2-pyridineoxydiaryl ketone derivative - Google Patents

Preparation method of 2-pyridineoxydiaryl ketone derivative Download PDF

Info

Publication number
CN103242223A
CN103242223A CN2013101537635A CN201310153763A CN103242223A CN 103242223 A CN103242223 A CN 103242223A CN 2013101537635 A CN2013101537635 A CN 2013101537635A CN 201310153763 A CN201310153763 A CN 201310153763A CN 103242223 A CN103242223 A CN 103242223A
Authority
CN
China
Prior art keywords
pyridyloxy
preparation
ketone derivatives
diaryl ketone
silver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013101537635A
Other languages
Chinese (zh)
Other versions
CN103242223B (en
Inventor
张玉红
姚金忠
冯若昆
刘占祥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN201310153763.5A priority Critical patent/CN103242223B/en
Publication of CN103242223A publication Critical patent/CN103242223A/en
Application granted granted Critical
Publication of CN103242223B publication Critical patent/CN103242223B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention discloses a preparation method of 2-pyridineoxydiaryl ketone derivative. The preparation method comprises the following steps of: adding a catalyst, an oxidant, a 2-pyridineoxydiaryl compound and aryl oxoacetic acid to an organic solvent; heating up to 90-120 DEG C; and posttreating to obtain 2-pyridineoxydiaryl ketone derivative after the reaction is completed. The preparation method of the pyridineoxydiaryl ketone derivative disclosed by the invention is easy to operate, simple in posttreatment, strong in substrate designability, capable of designing a compound for synthesizing the needed structure according to actual needs, and stronger in practicability. Meanwhile, the compound prepared by the preparation method is good in bioactivity, can be used as the material for synthesizing various 2-pyridineoxydiaryl ketone derivative compounds and is higher in economic value.

Description

A kind of preparation method of 2-pyridyloxy diaryl ketone derivatives
Technical field
The invention belongs to the organic synthesis field, be specifically related to a kind of preparation method of 2-pyridyloxy diaryl ketone derivatives.
Background technology
2-pyridyloxy diaryl ketone is the very important organic intermediate of a class, and it extensively is present in the natural product as a kind of important nitrogen heterocyclic ring.For example the mother nucleus structure of the multiple resistive connection intestinal cancer compound that extracts in the yellow fruit of tonkin tinomiscium stem is exactly the diaryl ketone.(Bioactive?Benzophenonesfrom?Garcinia?xanthochymus?Fruits,J.Nat.Prod.2005,68,354-360)
The functionalization of deriving of this compounds has caused a large amount of study on the synthesis persons' interest.For example its derivative can be used as the non-nucleoside reverse transcriptase inhibitor (NNRTI) of anti-HIV-1. (Practical snthesis of a benzophenone-based NNRT inhibitor of HIV-1, Org.Process Res.Dev.2012,16,561-566)
In addition, 2-pyridyloxy diaryl ketone will produce 2-hydroxyl diaryl methanone compounds through hydrolysis, and hydrolytic process is simple, easy handling and realization industrialization.2-hydroxyl diaryl methanone compounds is very important organic raw material, it can be used as the raw material of more synthetic medicines, for example patent application WO2012041860A1 discloses the method for the synthetic class indole derivatives of a kind of 2-of use dihydroxy benaophenonel, and such indole derivatives can be used as a kind of histamine H 4Receptor antibody.
Summary of the invention
The invention provides a kind of preparation method of 2-pyridyloxy diaryl ketone derivatives, this method steps is simple, and the by product of reaction is carbonic acid gas and water, and environmental pollution is little.
A kind of preparation method of 2-pyridyloxy diaryl ketone derivatives, comprise: with catalyzer, oxygenant, 2-pyridyloxy aryl compound and aryl formyl formic acid join in the organic solvent, be heated to 90~120 ℃, reacting completely obtains described 2-pyridyloxy diaryl ketone derivatives by aftertreatment;
The structure of described 2-pyridyloxy aryl compound is suc as formula shown in (II):
Figure BDA00003113974400021
(II);
The structure of described aryl formyl formic acid is suc as formula shown in (III):
Figure BDA00003113974400022
(III);
The structure of described 2-pyridyloxy diaryl ketone derivatives is suc as formula shown in (I):
Figure BDA00003113974400023
(I);
Among formula (I)-Shi (III): R 1Be hydrogen, halogen, C 1~C 5Alkyl or C 1~C 5Alkoxyl group;
R 2Be hydrogen, halogen, C 1~C 5Alkyl, C 1~C 5Alkoxyl group or trifluoromethyl;
Described catalyzer is the divalence palladium catalyst;
Described oxygenant is monovalence silver oxygenant.
Above-mentioned reaction process is shown below:
Figure BDA00003113974400024
As shown in Figure 1, preparation method's of the present invention possible reaction mechanism is as follows: described divalence palladium catalyst and 2-pyridyloxy diaryl ketone derivatives are (with R 1=H is example) in pyridine N atom carry out coordination after, generation intermediate A in activation back takes place in the ortho position c h bond to the 2-pyridyloxy, form intermediate B after intermediate A and the aryl formyl formic acid generation metal exchange, and then generation decarboxylic reaction, generate intermediate C, reduction takes place intermediate C eliminates the described 2-pyridyloxy diaryl ketone derivatives of generation, and discharges the zeroth order palladium, the zeroth order palladium regenerates the divalence palladium catalyst under the effect of oxygenant then, finishes catalytic cycle.Among this preparation method, by product was water and carbonic acid gas after reaction was finished, and environmental pollution is little, and reaction raw materials becomes more readily available, and cost is lower.
As preferably, described R 1Be hydrogen, fluorine, chlorine, bromine, methyl or methoxy, at this moment, these 2-pyridyloxy aryl compounds (II) can select for use existing method to prepare, and for example can select for use 2-bromopyridine and fragrant phenol to obtain under the effect of monovalence copper and alkali.
As further preferred, described R 2Be hydrogen, fluorine, chlorine, bromine, methyl, methoxyl group or trifluoromethyl, this moment, raw material aryl formyl formic acid cheaply was easy to get, and reaction yield is higher.
As preferably, described organic solvent is dioxane, acetic acid or methyl-sulphoxide, and the consumption of reaction solvent does not have strict especially requirement, raw material fully can be dissolved to get final product.
As preferably, described divalence palladium catalyst comprises palladium, dichloro diacetonitrile palladium (Pd (CH 3CN) 2Cl 2) or Palladous chloride, these divalence palladium catalysts can both be buied easily from the market.
As preferably, described monovalence silver oxygenant is Silver monoacetate, silver carbonate, silver suboxide or Silver Nitrate, and these oxygenants can both be buied easily from the market.
In the above-mentioned reaction, for economizing in raw materials, guarantee carrying out fully of reaction simultaneously, as preferably, the mol ratio of described 2-pyridyloxy aryl compound, aryl formyl formic acid, catalyzer and oxygenant is 1:2-4:0.1-0.3:1-3.
The reaction degree of carrying out can be by the TLC(thin-layer chromatography) monitor, as preferably, the reaction times is 6-12 hour, long increase reaction cost of reaction times, opposite then be difficult to guarantee to react complete.
As further preferred, described divalence palladium catalyst is dichloro diacetonitrile palladium;
Described monovalence silver oxygenant is silver suboxide;
Temperature of reaction is 110~115 ° of C, and at this moment, the productive rate of reaction is the highest, and side reaction is minimum.
As preferably, described 2-pyridyloxy diaryl ketone derivatives is selected from shown in formula (I-1)-Shi (I-10) a kind of in the compound:
Figure BDA00003113974400031
(I-1)
Figure BDA00003113974400032
(I-2)
Figure BDA00003113974400041
(I-3)
(I-4)
Figure BDA00003113974400043
(I-5)
Figure BDA00003113974400044
(I-6)
Figure BDA00003113974400045
(I-7)
Figure BDA00003113974400046
(I-8)
Figure BDA00003113974400047
(I-9)
Figure BDA00003113974400048
(I-10)。
After above-mentioned reaction was finished, available last handling process comprised: filter, silica gel mixed sample obtains corresponding 2-pyridyloxy diaryl ketone derivatives finally by crossing column chromatography purification.
The preparation method of 2-pyridyloxy diaryl ketone derivatives of the present invention, easy handling, aftertreatment is easy, and the substrate designability is strong, can design the compound that synthesizes desired structure according to actual needs, and practicality is stronger.Simultaneously, the compound biological activity that is obtained by method for preparing is good, can be used as the synthetic various 2-hydroxyl diaryl methanone compounds of raw material simultaneously, has higher economic value.
Description of drawings
Fig. 1 is the preparation method's of 2-pyridyloxy diaryl ketone derivatives of the present invention reaction mechanism figure.
Embodiment
Embodiment 1~10
Proportioning raw materials according to table 1 adds catalyzer, oxygenant, 2-pyridyloxy aryl compound (II), aryl formyl formic acid (III) and organic solvent 2ml in the Schlenk of 35ml pipe, mixing and stirring, after finishing according to the reaction of the reaction conditions of table 2, filter, silica gel mixed sample, obtain corresponding 2-pyridyloxy diaryl ketone derivatives (I) through column chromatography (eluent is sherwood oil) purifying, reaction process is shown below:
Figure BDA00003113974400051
Table 1
Figure BDA00003113974400052
Table 2
Figure BDA00003113974400061
In table 1 and the table 2, T is temperature of reaction, and t is the reaction times, and Me is methyl, and OMe is methoxyl group, and p represents para-orientation, and m represents that the ortho position replaces.
Application examples 1
(CAS number: preparation 117-99-7): (138mg 0.5mmol) is dissolved in 5 milliliters the toluene compound (I-1) that embodiment 1 is prepared the 2-dihydroxy benaophenonel, adds 0.1mL trifluoromethanesulfonic acid methyl esters.Be heated to 100 ° of C, react 2 hours stopped reaction, revolve except toluene.Residue is dissolved in 5 milliliters the methyl alcohol, (270mg 5mmol), is heated to 80 ° of C reactions 0.5 hour to add sodium methylate.The reaction solution cool to room temperature, water and ethyl acetate layering, organic phase is collected, the saturated common salt water washing, anhydrous magnesium sulfate drying filters, and be spin-dried for and namely obtain product 2-dihydroxy benaophenonel 81mg, productive rate 82%, the nuclear magnetic data of products obtained therefrom is as follows:
1H?NMR(400MHz,CDCl 3,TMS)δ12.1(s,1H),7.69-7.67(m,2H),7.61-7.58(m,2H),7.51-7.49(m,3H),7.08(d,J=8.4Hz,1H),6.90-6.86(m,1H);
13C?NMR(100MHz,CDCl 3)δ201.6,163.2,137.8,136.3,133.6,131.9,129.1,128.3,119.1,118.6,118.4.
Figure BDA00003113974400062
Application examples 2
(CAS number: preparation 131-57-7): (153mg 0.5mmol) is dissolved in 5 milliliters the toluene compound (I-9) that embodiment 9 is prepared 4-methoxyl group-2-dihydroxy benaophenonel, adds 0.1mL trifluoromethanesulfonic acid methyl esters.Be heated to 100 ° of C, react 2 hours stopped reaction, revolve except toluene.Residue is dissolved in 5 milliliters the methyl alcohol, (270mg 5mmol), is heated to 80 ° of C reactions 0.5 hour to add sodium methylate.The reaction solution cool to room temperature, water and ethyl acetate layering, organic phase is collected, the saturated common salt water washing, anhydrous magnesium sulfate drying filters, and be spin-dried for and namely obtain product 2-dihydroxy benaophenonel 96mg, productive rate 84%, the nuclear magnetic data of products obtained therefrom is as follows:
1H?NMR(400MHz,CDCl 3,TMS)δ12.20(s,1H),7.69-7.54(m,2H),7.56-7.51(m,1H),7.47-7.43(m,2H),7.15(d,J=8.0Hz,1H),7.06(d,J=8.0Hz,1H),6.78-6.76(m,1H),3.89(s,3H);
13C?NMR(100MHz,CDCl 3)δ201.6,153.2,148.8,137.7,131.8,128.1,124.6,124.3,119.1,117.9,116.9,56.1.
Figure BDA00003113974400071
Embodiment 1~10 prepares the structural confirmation data of compound:
The structure detection data of the 2-pyridyloxy diaryl ketone derivatives that is prepared by embodiment 1~10 are respectively:
The 2-pyridyloxy diaryl ketone derivatives that is prepared by embodiment 1 (I-1, CAS number: nucleus magnetic resonance 1173294-85-3) ( 1H NMR and 13C NMR) detecting data is:
Figure BDA00003113974400072
(I-1)
1H?NMR(400MHz,CDCl 3,TMS)δ8.01(d,J=4.0Hz,1H),7.75(d,J=8.0Hz,2H),7.59-7.45(m,4H),7.35-7.28(m,4H),6.87(t,J=6.4Hz,1H),6.60(d,J=8.4Hz,1H); 13C?NMR(100MHz,CDCl 3)δ195.3,162.8,151.5,146.9,139.3,137.4,132.7,132.1,130.2,129.7,127.9,124.6,122.7,118.4,111.4.
The 2-pyridyloxy diaryl ketone derivatives that is prepared by embodiment 2 (I-2, CAS number: nucleus magnetic resonance 1173294-97-7) ( 1H NMR and 13C NMR) detecting data is:
Figure BDA00003113974400081
(I-2)
1H?NMR(400MHz,CDCl 3,TMS)δ8.01(d,J=4.0Hz,1H),7.67(d,J=8.0Hz,2H),7.56-7.49(m,3H),7.31-7.24(m,2H),7.13(d,J=8.4Hz,2H),6.86(t,J=7.2Hz,1H),6.64(d,J=8.4Hz,1H),2.35(s,3H);
13C?NMR(100MHz,CDCl 3)δ194.5,162.9,151.4,146.9,143.6,139.2,134.7,132.4,131.7,130.0,129.9,128.7,124.5,122.6,118.4,111.4,21.6.
The nucleus magnetic resonance of the 2-pyridyloxy diaryl ketone derivatives (I-3) that is prepared by embodiment 3 ( 1H NMR and 13C NMR) detecting data is:
Figure BDA00003113974400082
(I-3)
1H?NMR(400MHz,CDCl 3,TMS)δ8.01(d,J=4.0Hz,1H),7.55-7.51(m,3H),7.33-7.27(m,3H),7.25-7.19(m,2H),7.01(d,J=8.0,4.0Hz,1H),6.87(d,J=8.0Hz,1H),6.62(d,J=8.0Hz,1H),3.75(s,3H);
13C?NMR(100MHz,CDCl 3)δ195.0,162.9,159.3,151.5,146.9,139.3,138.7,132.1,132.0,130.1,128.9,124.5,122.9,122.7,119.6,118.4,113.1,111.4,55.3.
The nucleus magnetic resonance of the 2-pyridyloxy diaryl ketone derivatives (I-4) that is prepared by embodiment 4 ( 1H NMR and 13C NMR) detecting data is:
Figure BDA00003113974400083
(I-4)
1H?NMR(400MHz,CDCl 3,TMS)δ8.00(d,J=4.0Hz,1H),7.78(d,J=8.4,2.8Hz,2H),7.59-7.51(m,3H),7.31(t,J=7.6Hz,1H),7.25(d,J=7.6Hz,1H),6.99(t,J=8.8Hz,2H),6.88(t,J=6.4Hz,1H),6.62(d,J=8.4Hz,1H);
13C?NMR(100MHz,CDCl 3)δ193.7,165.5(J=253Hz),162.7,151.4,146.9,139.4,133.7(J=2.0Hz),132.4(J=8.9Hz),132.2,131.9,130.0,124.7,122.6,118.6,115.1(J=21.5Hz),111.4.
The nucleus magnetic resonance of the 2-pyridyloxy diaryl ketone derivatives (I-5) that is prepared by embodiment 5 ( 1H NMR and 13C NMR) detecting data is:
Figure BDA00003113974400091
(I-5)
1H?NMR(400MHz,CDCl 3,TMS)δ8.01(d,J=4.4Hz,1H),7.70(d,J=7.2Hz,2H),7.59-7.52(m,3H),7.34-7.25(m,4H),6.89(t,J=6.4Hz,1H),6.62(d,J=8.0Hz,1H);
13C?NMR(100MHz,CDCl 3)δ194.1,162.7,151.5,146.9,139.4,139.1,135.8,132.4,131.7,131.1,130.1,128.3,124.8,122.7,118.6,111.5.
The 2-pyridyloxy diaryl ketone derivatives that is prepared by embodiment 6 (I-6, CAS number: nucleus magnetic resonance 1173294-98-8) ( 1H NMR and 13C NMR) detecting data is:
Figure BDA00003113974400092
(I-6)
1H?NMR(400MHz,CDCl 3,TMS)δ8.00(d,J=4.0Hz,1H),7.63-7.53(m,5H),7.46(d,J=8.8Hz,2H),7.31(t,J=7.6Hz,1H),7.26-7.24(m,1H),6.89(t,J=5.6Hz,1H),6.62(d,J=8.8Hz,1H);
13C?NMR(125MHz,CDCl 3)δ194.2,162.7,151.5,146.9,139.4,136.2,132.4,131.6,131.3,131.2,130.1,127.8,124.7,122.7,118.6,111.5.
The nucleus magnetic resonance of the 2-pyridyloxy diaryl ketone derivatives (I-7) that is prepared by embodiment 7 ( 1H NMR and 13C NMR) detecting data is:
Figure BDA00003113974400093
(I-7)
1H?NMR(400MHz,CDCl 3,TMS)δ8.00-7.98(m,2H),7.93(d,J=8.0Hz,1H),7.70(d,J=8.0Hz,1H),7.61-7.59(m,2H),7.50-7.46(m,2H),7.35(t,J=7.2Hz,1H),7.28-7.26(m,1H),6.90-6.87(m,1H),6.55(d,J=8.0Hz,1H);
13C?NMR(100MHz,CDCl 3)δ194.0,162.6,151.7,147.0,139.4,138.3,132.8(2C),131.2,130.6(q,J=33.4Hz),130.1,129.0(q,J=3.7Hz),128.6,126.5(q,J=3.4Hz),124.9,123.6(q,J=265Hz),122.8,118.7,111.3.
The nucleus magnetic resonance of the 2-pyridyloxy diaryl ketone derivatives (I-8) that is prepared by embodiment 8 ( 1H NMR and 13C NMR) detecting data is:
Figure BDA00003113974400101
(I-8)
1H?NMR(400MHz,CDCl 3,TMS)δ8.01(d,J=4.0Hz,1H),7.74(d,J=7.6Hz,2H),7.48-7.44(m,2H),7.38-7.36(m,2H),7.31(t,J=7.6Hz,2H),7.15(d,J=8.8Hz,1H),6.85(t,J=6.8Hz,1H),6.55(d,J=8.0Hz,1H),2.40(s,3H);
13C?NMR(100MHz,CDCl 3)δ195.5,163.1,149.2,146.9,139.1,137.5,134.5,132.8,132.6,131.9,130.5,129.8,127.9,122.6,118.2,111.2,20.8.
The 2-pyridyloxy diaryl ketone derivatives that is prepared by embodiment 9 (I-9, CAS number: nucleus magnetic resonance 1173294-88-6) ( 1H NMR and 13C NMR) detecting data is:
Figure BDA00003113974400102
(I-9)
1H?NMR(400MHz,CDCl 3,TMS)δ8.01(d,J=5.2Hz,1H),7.74(d,J=8.0Hz,2H),7.48-7.44(m,2H),7.31(t,J=7.6Hz,2H),7.19(d,J=8.8Hz,1H),7.12-7.07(m,2H),6.84(t,J=6.4Hz,1H),6.52(d,J=8.4Hz,1H),3.83(s,3H);
13C?NMR(100MHz,CDCl 3)δ195.0,163.3,156.3,146.9,144.8,139.1,137.3,132.9,132.8,129.7,127.9,124.1,118.1,118.0,114.4,111.0,55.7.
The nucleus magnetic resonance of the 2-pyridyloxy diaryl ketone derivatives (I-10) that is prepared by embodiment 10 ( 1H NMR and 13C NMR) detecting data is:
Figure BDA00003113974400111
(I-10)
1H?NMR(400MHz,CDCl 3,TMS)δ8.00(d,J=3.6Hz,1H),7.75(d,J=7.2Hz,2H),7.53-7.48(m,2H),7.34(t,J=8.0Hz,2H),7.28-7.26(m,3H),6.88(t,J=6.0Hz,1H),6.58(d,J=8.4Hz,1H);
13C?NMR(100MHz,CDCl 3)δ193.8,162.8,159.0(J=245.3Hz),147.2(J=3.2Hz),146.8,139.4,136.8,133.5(J=7.2Hz),133.1,129.7,128.1,124.6(J=8.9Hz),118.8(J=23.9Hz),118.5,116.6(J=24.6Hz),111.3。

Claims (10)

1. the preparation method of a 2-pyridyloxy diaryl ketone derivatives, it is characterized in that, comprise: catalyzer, oxygenant, 2-pyridyloxy aryl compound and aryl formyl formic acid are joined in the organic solvent, be heated to 90~120 ℃, reacting completely obtains described 2-pyridyloxy diaryl ketone derivatives by aftertreatment;
The structure of described 2-pyridyloxy aryl compound is suc as formula shown in (II):
Figure FDA00003113974300011
(II);
The structure of described aryl formyl formic acid is suc as formula shown in (III):
(III);
The structure of described 2-pyridyloxy diaryl ketone derivatives is suc as formula shown in (I):
Figure FDA00003113974300013
(I);
Among formula (I)-Shi (III), R 1Be hydrogen, halogen, C 1~C 5Alkyl or C 1~C 5Alkoxyl group;
R 2Be hydrogen, halogen, C 1~C 5Alkyl, C 1~C 5Alkoxyl group or trifluoromethyl;
Described catalyzer is the divalence palladium catalyst;
Described oxygenant is monovalence silver oxygenant.
2. the preparation method of 2-pyridyloxy diaryl ketone derivatives according to claim 1 is characterized in that described R 1Be hydrogen, fluorine, chlorine, bromine, methyl or methoxy.
3. the preparation method of 2-pyridyloxy diaryl ketone derivatives according to claim 2 is characterized in that described R 2Be hydrogen, fluorine, chlorine, bromine, methyl, methoxyl group or trifluoromethyl.
4. according to the preparation method of each described 2-pyridyloxy diaryl ketone derivatives of claim 1~3, it is characterized in that described organic solvent is dioxane, acetic acid or methyl-sulphoxide.
5. according to the preparation method of each described 2-pyridyloxy diaryl ketone derivatives of claim 1~3, it is characterized in that described divalence palladium catalyst comprises palladium, dichloro diacetonitrile palladium or Palladous chloride.
6. according to the preparation method of each described 2-pyridyloxy diaryl ketone derivatives of claim 1~3, it is characterized in that described monovalence silver oxygenant is Silver monoacetate, silver carbonate, silver suboxide or Silver Nitrate.
7. according to the preparation method of each described 2-pyridyloxy diaryl ketone derivatives of claim 1~3, it is characterized in that the mol ratio of described 2-pyridyloxy aryl compound, aryl formyl formic acid, catalyzer and oxygenant is 1:2-4:0.1-0.3:1-3.
8. according to the preparation method of each described 2-pyridyloxy diaryl ketone derivatives of claim 1~3, it is characterized in that the reaction times is 6-12 hour.
9. according to the preparation method of each described 2-pyridyloxy diaryl ketone derivatives of claim 1~3, it is characterized in that described divalence palladium catalyst is dichloro diacetonitrile palladium;
Described monovalence silver oxygenant is silver suboxide;
Temperature of reaction is 100~115 ° of C.
10. the preparation method of 2-pyridyloxy diaryl ketone derivatives according to claim 9 is characterized in that, described 2-pyridyloxy diaryl ketone derivatives is selected from shown in formula (I-1)-Shi (I-10) a kind of in the compound:
Figure FDA00003113974300021
(I-1)
Figure FDA00003113974300022
(I-2)
Figure FDA00003113974300023
(I-3)
Figure FDA00003113974300031
(I-4)
Figure FDA00003113974300032
(I-5)
Figure FDA00003113974300033
(I-6)
Figure FDA00003113974300034
(I-7)
Figure FDA00003113974300035
(I-8)
Figure FDA00003113974300036
(I-9)
(I-10)。
CN201310153763.5A 2013-04-27 2013-04-27 Preparation method of 2-pyridineoxydiaryl ketone derivative Expired - Fee Related CN103242223B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310153763.5A CN103242223B (en) 2013-04-27 2013-04-27 Preparation method of 2-pyridineoxydiaryl ketone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310153763.5A CN103242223B (en) 2013-04-27 2013-04-27 Preparation method of 2-pyridineoxydiaryl ketone derivative

Publications (2)

Publication Number Publication Date
CN103242223A true CN103242223A (en) 2013-08-14
CN103242223B CN103242223B (en) 2015-05-13

Family

ID=48922129

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310153763.5A Expired - Fee Related CN103242223B (en) 2013-04-27 2013-04-27 Preparation method of 2-pyridineoxydiaryl ketone derivative

Country Status (1)

Country Link
CN (1) CN103242223B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105418393A (en) * 2015-11-27 2016-03-23 陕西师范大学 Two-step one-pot synthesis method for meta-substituted diphenyl ketone compound
CN107879911A (en) * 2017-10-25 2018-04-06 绍兴文理学院 A kind of method that aromatic ketone is prepared in aqueous phase

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JINZHONG YAO,等: "Palladium-Catalyzed Decarboxylative Coupling of α-Oxocarboxylic Acids with C(sp2)-H of 2-Aryloxypyridines", 《ADV. SYNTH. CATAL.》 *
MINGZONG LI等: "Decarboxylative Acylation of Arenes with α-Oxocarboxylic Acids via Palladium-Catalyzed C-H Activation", 《ORGANIC LETTERS》 *
PING FANG,等: "Room Temperature Palladium-Catalyzed Decarboxylative ortho-Acylation of Acetanilides with α-Oxocarboxylic Acids", 《J. AM. CHEM. SOC.》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105418393A (en) * 2015-11-27 2016-03-23 陕西师范大学 Two-step one-pot synthesis method for meta-substituted diphenyl ketone compound
CN105418393B (en) * 2015-11-27 2018-07-10 陕西师范大学 Two step one-pot synthesis methods of meta position substituted benzophenone class compound
CN107879911A (en) * 2017-10-25 2018-04-06 绍兴文理学院 A kind of method that aromatic ketone is prepared in aqueous phase
CN107879911B (en) * 2017-10-25 2020-12-18 绍兴文理学院 Method for preparing aromatic ketone in water phase

Also Published As

Publication number Publication date
CN103242223B (en) 2015-05-13

Similar Documents

Publication Publication Date Title
CN107698586B (en) Method for preparing pyridoquinazolinone compound by catalysis of copper compound
CN102827077A (en) Preparation method for phenanthridine derivative
CN112321593B (en) Preparation method of indolo [1,2-a ] quinazoline-6 (5H) -ketone compound
CN103304393B (en) A kind of synthetic method of benzil analog derivative
CN103242223B (en) Preparation method of 2-pyridineoxydiaryl ketone derivative
CN112724168B (en) Chiral pyridine derived N, B ligand, preparation method and application in iridium-catalyzed asymmetric boronation reaction
CN102558174A (en) New pyrazolo[4,3-c]pyridine compound and synthesis method thereof
CN102603735B (en) Preparation method of C-2 arylation indolizine compound
CN103408525B (en) A kind of synthetic method of flavonoid compound and application thereof
CN104370930A (en) Method for efficiently preparing di(hetero)arylbenzopyrone/cyclopentanone derivative through rhodium catalysis-based C-H/C-H oxidation coupling reaction
CN103242371B (en) Biaryl pyridine ring palladium N-heterocyclic carbine compound and its production and use
CN109020935A (en) A kind of dibenzofuran derivative and preparation method thereof
CN102127014B (en) Azaphenanthrone compound and preparation method thereof
CN102093355B (en) C-3 acylated indolizine compound and preparation method thereof
CN102351790A (en) Method for synthesizing 7-bromo-6-chloro-4-quinazolinone
CN103992325B (en) A kind of synthetic method of N-phenyl indazole [3,2-b] quinazoline-7 (5H)-one derivative
CN113149895B (en) Method for synthesizing isoquinolone compounds or pyridone compounds
CN104876929A (en) Synthesis method and application of 1,2,3,4-tetrahydronaphthyridine compound
CN103304520A (en) Preparation method of multi-substituted furan compound
CN103804201A (en) Synthesis method for intermediate 3-aminophenylacetylene of antitumor drug erlotinib
CN102603624B (en) Preparation method of 2-pyridine carboxamide diaryl ketone compound as well as compound
CN103113291B (en) Synthesis method of 3-position alkenyl pyridine derivatives
CN105198936A (en) Preparation of metal coordination polymer containing benzenesulfonic acid cobalt and catalytic activity thereof
CN102093354B (en) Indolizine Mannich base compound and preparation method thereof
CN104788370B (en) A kind of method that configuration controllably synthesizes 2 (4 nitro) bytyry N-oxide compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150513

Termination date: 20160427